Funny.  According to the Craog Hallum website, there is no such report from Alex Nowak yesterday.  He publilshed on three companies yesterday, Accelerate Diagnostics, Tandem Diabetes Care, and NeuroOne Medical Technologies.  Given that roster of reports, he sounds like he would not be the right analyst for POET - very different from healthcare. 

And I should note - Richard Shannon is still listed as being with the firm, so a transfer of coverage seems unlikely.